Poly Medicure reschedules investor meet to Jun 24
Poly Medicure Limited has rescheduled its one-on-one investor meeting with Ikigai Asset to June 24, 2026, at 11:00 AM IST. The physical meeting will be held at the company's registered office in New Delhi. The company confirmed that no unpublished price sensitive information will be shared during the interaction.

*this image is generated using AI for illustrative purposes only.
Poly Medicure Limited has rescheduled its one-on-one investor meeting with Ikigai Asset to June 24, 2026, at 11:00 AM IST. The meeting was originally set for June 23, 2026, and will be held physically at the company's registered office in New Delhi. The rescheduling was communicated pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The venue and format of the interaction remain unchanged. The session will be conducted as a one-on-one physical meeting at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020. The company confirmed that no unpublished price sensitive information would be shared during the meeting.
The revised schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company. The disclosure was signed by Avinash Chandra, Company Secretary of Poly Medicure Limited.
Rescheduled Meeting Details
| Investor's | Meeting Date | Venue | Format | Re-scheduled Date |
|---|---|---|---|---|
| Ikigai Asset | Tuesday, 23 June 2026 at 12:00 PM | Physical Meeting at Company Registered Office at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020 | One-on-one | Wednesday, 24 June 2026 at 11:00 AM |
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.59% | -3.61% | +17.62% | -9.68% | -26.70% | +67.49% |
What specific strategic initiatives or growth areas is Poly Medicure likely to emphasize during this meeting with Ikigai Asset?
Could the rescheduling indicate preparations for a significant corporate announcement or shift in strategy prior to the interaction?
How might the outcome of this meeting influence Ikigai Asset's current investment stance or shareholding in Poly Medicure?





























